Evidence map›Paper›PMID 27705905›Full record

ArticleOncotarget2016

Adipocytes cause leukemia cell resistance to daunorubicin via oxidative stress response.

Xia Sheng, Jonathan Tucci, Jean-Hugues Parmentier, Lingyun Ji, James W Behan, Nora Heisterkamp, Steven D Mittelman

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Co-culture shock.Cell death discovery · 2026
    Article
  3. Article
  4. Article
  5. Nutrients Lowering Obesity-Linked Chemokines Blamable for Metastasis.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. The 'omics of obesity in B-cell acute lymphoblastic leukemia.Journal of the National Cancer Institute. Monographs · 2023
    Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xia ShengDiabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Jonathan TucciDiabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Jean-Hugues ParmentierDiabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Lingyun JiDepartment of Biostatistics, Children's Hospital Los Angeles, Los Angeles, CA, USA.
James W BehanDiabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Nora HeisterkampDivision of Hematology/Oncology and Bone Marrow Transplant, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Steven D MittelmanDiabetes and Obesity Program, Center for Endocrinology, Diabetes and Metabolism, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Children's Hospital of Los Angeles · USUniversity of Southern California · US

Funding

TREATMENT OF BCR/ABL CAUSED LEUKEMIAS WITH FTIsR01CA090321 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI HEISTERKAMP, NORA C · 2001 to 2017
$4.4M
Adipocytes are Important Players in the Acute Lymphoblastic Leukemia MicroenvironmentR01CA201444 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MITTELMAN, STEVEN DAVID · 2016 to 2020
$1.9M
Microenvironment-Leukemia Communication Through LectinsR01CA172040 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI HEISTERKAMP, NORA C · 2013 to 2017
$1.7M
Investigating the Role of Adipocytes on Leukemia RelapseR01CA139060 · NCI · CHILDREN'S HOSPITAL OF LOS ANGELES · PI MITTELMAN, STEVEN DAVID · 2009 to 2013
$1.6M
NCI NIH HHS R01 CA090321NCI NIH HHS R01 CA139060NCI NIH HHS R01 CA172040NCI NIH HHS R01 CA201444
6 · The paper itself

Abstract

Adipocytes promote cancer progression and impair treatment, and have been shown to protect acute lymphoblastic leukemia (ALL) cells from chemotherapies. Here we investigate whether this protection is mediated by changes in oxidative stress. Co-culture experiments showed that adipocytes protect ALL cells from oxidative stress induced by drugs or irradiation. We demonstrated that ALL cells induce intracellular ROS and an oxidative stress response in adipocytes. This adipocyte oxidative stress response leads to the secretion of soluble factors which protect ALL cells from daunorubicin (DNR). Collectively, our investigation shows that ALL cells elicit an oxidative stress response in adipocytes, leading to adipocyte protection of ALL cells against DNR.

Indexed as

Drug Resistance, NeoplasmOxidative Stress3T3-L1 CellsAdipocytesAnimalsAntibiotics, AntineoplasticAntioxidantsCell DeathCell Line, TumorDaunorubicinGene Expression ProfilingGlutathioneHumansLeukemiaMicePrecursor Cell Lymphoblastic Leukemia-LymphomaAntibiotics, AntineoplasticAntioxidantsDaunorubicinGlutathioneReactive Oxygen SpeciesadipocyteALLdrug resistanceglutathioneoxidative stress

Identifiers

PMID27705905
PMCPMC5341969
OpenAlexW2523998273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.